Trials / Completed
CompletedNCT05032404
Blue Note Therapeutics Product BNT 103 Usability and User Engagement
BNT 103 Usability and User Engagement
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Blue Note Therapeutics · Industry
- Sex
- Female
- Age
- 35 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
This test aims to explore product development-focused usability and user engagement.
Detailed description
Sponsor is testing an innovative peer-to-peer communication tool during this trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | BNT103 | BNT-103™ is a prescription digital therapeutic specifically designed to treat the symptoms of anxiety and depression related to cancer. There are 10 sessions provided over approximately 10 weeks. |
Timeline
- Start date
- 2021-09-01
- Primary completion
- 2021-10-26
- Completion
- 2021-12-31
- First posted
- 2021-09-02
- Last updated
- 2022-10-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05032404. Inclusion in this directory is not an endorsement.